The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients (Q57168537)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

0 references

Zhijing Na

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Xinbo Qiao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Ling Fan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Yao Xiao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Yining Shao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Mingwei Sun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Ziyi Feng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Wen Guo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jiapo Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jiatong Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Dongyang Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

language of work or name

English

0 references

publication date

20 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

published in

OncoTargets and Therapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

4913-4944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

20 April 2020

start time

1 August 2018

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person-years of follow-up.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

2 November 2018

Cancer Statistics, 2017.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

β-Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Can analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Elucidating the role of incidental use of beta-blockers in patients with metastatic brain tumors in controlling tumor progression and survivability

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Meta-analysis of the effects of beta blocker on survival time in cancer patients

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Perioperative beta-blocker use and survival in lung cancer patients.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Does beta-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer?

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

β-blockers: a new role in cancer chemotherapy?

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Impact of beta blockers on epithelial ovarian cancer survival

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Treatment and outcomes of acute coronary syndrome in the cancer population

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Practical methods for incorporating summary time-to-event data into meta-analysis

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Beta-blockers for hypertension

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Stage-specific associations between beta blocker use and prognosis after colorectal cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6109661

Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease

30 November 2018

1 reference

12 December 2020

Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study

1 reference

12 December 2020

Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer

1 reference

12 December 2020

β-Blocker Use and Risk of Recurrence in Patients with Early Breast Cancer

1 reference

12 December 2020

Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.2147/OTT.S167422

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

PubMed publication ID

30174436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30174436%20AND%20SRC:MED&resulttype=core&format=json